Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antineoplastic drugs in 1990. A review (Part II).

× No keyword cloud information.

356 in total

1. Subcutaneous fat necrosis with acute hemorrhagic pancreatitis-a case in a child with steroid-resistant nephrosis treated with 6-mercaptopurine.

Authors: E Heuser; E Lieberman; G N Donnell; B H Landing
Journal: Calif Med Date: 1967-01

2. Pharmacokinetics of vindesine and vincristine in humans.

Authors: R J Owellen; M A Root; F O Hains
Journal: Cancer Res Date: 1977-08 Impact factor: 12.701

3. Cancer chemotherapy and skin changes.

Authors: N J Vogelzang; M J Ratain
Journal: Ann Intern Med Date: 1985-08 Impact factor: 25.391

4. Increase in hepatic metallothionein in rats treated with alkylating agents.

Authors: F N Kotsonis; C D Klaassen
Journal: Toxicol Appl Pharmacol Date: 1979-10 Impact factor: 4.219

Review 5. Multidrug resistance.

Authors: J A Moscow; K H Cowan
Journal: J Natl Cancer Inst Date: 1988-03-02 Impact factor: 13.506

6. Response of preleukemic syndromes to continuous infusion of low-dose cytarabine.

Authors: J S Wisch; J D Griffin; D W Kufe
Journal: N Engl J Med Date: 1983-12-29 Impact factor: 91.245

7. The management of superficial bladder cancer.

Authors: M S Soloway
Journal: Cancer Date: 1980-04-15 Impact factor: 6.860

8. Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congeners.

Authors: J D Loike; C F Brewer; H Sternlicht; W J Gensler; S B Horwitz
Journal: Cancer Res Date: 1978-09 Impact factor: 12.701

9. Failure of 5-day vinblastine infusion in the treatment of patients with advanced refractory breast cancer.

Authors: I Tannock; C Erlichman; D Perrault; I Quirt; M King
Journal: Cancer Treat Rep Date: 1982-09

10. Synthesis, retention, and biological activity of methotrexate polyglutamates in cultured human breast cancer cells.

Authors: J Jolivet; R L Schilsky; B D Bailey; J C Drake; B A Chabner
Journal: J Clin Invest Date: 1982-08 Impact factor: 14.808

7 in total

Review 1. Cardiotoxicity of doxorubicin and other anthracycline derivatives.

Authors: D Jain
Journal: J Nucl Cardiol Date: 2000 Jan-Feb Impact factor: 5.952

Review 2. Drugs hazardous to healthcare workers. Evaluation of methods for monitoring occupational exposure to cytostatic drugs.

Authors: P J Sessink; R P Bos
Journal: Drug Saf Date: 1999-04 Impact factor: 5.606

3. Doxorubicin cardiotoxicity: prevention of congestive heart failure with serial cardiac function monitoring with equilibrium radionuclide angiocardiography in the current era.

Authors: Isao Mitani; Diwakar Jain; Tammy M Joska; Barbara Burtness; Barry L Zaret
Journal: J Nucl Cardiol Date: 2003 Mar-Apr Impact factor: 5.952

4. Clinical relevance of radionuclide angiography and antimyosin immunoscintigraphy for risk assessment in epirubicin cardiotoxicity.

Authors: C L Maini; R Sciuto; A Ferraironi; P Vici; A Tofani; A Festa; F Conti; M Lopez
Journal: J Nucl Cardiol Date: 1997 Nov-Dec Impact factor: 5.952

5. Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum.

Authors: M Kornmann; N Arber; M Korc
Journal: J Clin Invest Date: 1998-01-15 Impact factor: 14.808

6. Cancer risk assessment for health care workers occupationally exposed to cyclophosphamide.

Authors: P J Sessink; E D Kroese; H J van Kranen; R P Bos
Journal: Int Arch Occup Environ Health Date: 1995 Impact factor: 3.015

7. Mitoxantrone induces nonimmunological histamine release from rat mast cells.

Authors: M D Estévez; M R Vieytes; L M Botana
Journal: Inflamm Res Date: 1996-03 Impact factor: 4.575

7 in total